Citation tools
"Agent-based modelling reveals the role of the tumour microenvironment on the short-term success of combination temozolomide/immune checkpoint blockade to treat glioblastoma." Journal of Pharmacology and Experimental Therapeutics
(2023):
JPET-AR-2022-001571.
Web. 29 Nov. 2023.